Home Cart Sign in  
Alternatived Products of [ 1220696-34-3 ]
Product Citations

Product Details of [ 1220696-34-3 ]

CAS No. :1220696-34-3 MDL No. :MFCD16995982
Formula : C14H19BN2O2 Boiling Point : No data available
Linear Structure Formula :- InChI Key :HQQDRRKOLDTGHY-UHFFFAOYSA-N
M.W : 258.12 Pubchem ID :59534722
Synonyms :

Calculated chemistry of [ 1220696-34-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.5
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 77.47
TPSA : 36.28 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.28 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 2.25
Log Po/w (WLOGP) : 1.87
Log Po/w (MLOGP) : 1.31
Log Po/w (SILICOS-IT) : 1.32
Consensus Log Po/w : 1.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.14
Solubility : 0.186 mg/ml ; 0.00072 mol/l
Class : Soluble
Log S (Ali) : -2.65
Solubility : 0.581 mg/ml ; 0.00225 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.08
Solubility : 0.0217 mg/ml ; 0.0000839 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.95

Safety of [ 1220696-34-3 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1220696-34-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1220696-34-3 ]

[ 1220696-34-3 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 754214-56-7 ]
  • [ 74-88-4 ]
  • [ 1220696-34-3 ]
Reference: [1] Patent: WO2010/139747, 2010, A1, . Location in patent: Page/Page column 106
  • 2
  • [ 73183-34-3 ]
  • [ 183208-22-2 ]
  • [ 1220696-34-3 ]
YieldReaction ConditionsOperation in experiment
13.9 g With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 90℃; for 8 h; Inert atmosphere Step 2
1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine (compound 1-3)
Bis(pinacolato) borate (11.26 g, 43.6 mmol), PdCl2 (dppf) (814 mg, 1.11 mmol) and potassium acetate (6.53 g, 32.7 mmol) were added to a solution of compound 1-2 (4.6 g, 21.8 mmol) in 50 ml of 1,4-dioxane, and vigorously stirred under N2 atmosphere at 90° C. for 8 h.
After completion of the reaction, the mixture was filtered, and the filtrate was concentrated to give the crude product compound 1-3 (13.9 g) which was used directly in the next step. MS m/z (ESI): 259.1 [M+H]+.
Reference: [1] Patent: US2017/8889, 2017, A1, . Location in patent: Paragraph 0149; 0151
  • 3
  • [ 183208-35-7 ]
  • [ 1220696-34-3 ]
Reference: [1] Patent: US2017/8889, 2017, A1,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;